On the public citation graph

Discovery of Candesartan Cilexetic as a Novel Neddylation Inhibitor for Suppressing Tumor Growth

0 signed · 4 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4633119openalex-extracted

Design, Synthesis and in Vitro Antitumor Activity Evaluation of a Novel Neddylation Inhibitor

inferred← citeshttps://doi.org/10.1016/j.yexcr.2020.111858openalex-snapshot

Overexpression of ABCG2 confers resistance to pevonedistat, an NAE inhibitor

inferred← citeshttps://doi.org/10.3892/ijo.2023.5513openalex-snapshot

Targeting neddylation as a novel approach to lung cancer treatment (Review)

inferred← citeshttps://doi.org/10.7150/thno.78876openalex-snapshot

Targeting cullin neddylation for cancer and fibrotic diseases

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.